Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA approves Topamax for treatment of Lennox-Gastaut syndrome

Sep. 6, 2001

Axonyx updates phenserine development progress

Sep. 6, 2001

Antiviral effect seen for rhIL-12 monotherapy in pilot trial in patients with chronic HCV

Sep. 6, 2001

Lysophospholipid receptor ligands designed at U. of Virginia

Sep. 6, 2001

Antex's product development efforts continue as planned during Q2

Sep. 6, 2001

TNF overproduction attenuated by testosterone in blood from CHF patients

Sep. 6, 2001

Beneficial effects of allopurinol on peripheral blood flow in CHF

Sep. 6, 2001

Calcium sensitizers may be useful for enhancing myocardial contractile function in septic shock

Sep. 6, 2001

Ivabradine exerts selective bradycardic effects in exercised dogs

Sep. 6, 2001

FDA approves Medtronic's InSync cardiac resynchronization therapy device

Sep. 6, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...